[Skip to Content]
Sign In
Individual Sign In
Create an Account
Institutional Sign In
OpenAthens Shibboleth
Purchase Options:
[Skip to Content Landing]
Citations 0
From the Centers for Disease Control and Prevention
March 10, 1999

Change in Recommendation for Meningococcal Vaccine for Travelers

Author Affiliations

Copyright 1999 American Medical Association. All Rights Reserved. Applicable FARS/DFARS Restrictions Apply to Government Use.1999American Medical AssociationThis is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

JAMA. 1999;281(10):892. doi:10.1001/jama.281.10.892-JWR0310-3-1

MMWR. 1999;48:104

Because no evidence exists of ongoing epidemics, CDC no longer recommends meningococcal vaccine for travelers to Saudi Arabia, Nepal, India, Mongolia, Kenya, Burundi, and Tanzania. This announcement supersedes the most recent edition of Health Information for International Travel,1 which recommends meningococcal vaccine for those countries. These new recommendations will be reflected in the next edition of Health Information for International Travel.

Although CDC no longer recommends vaccination, Saudi officials may require that pilgrims and "Umra" performers produce a certificate of vaccination against meningococcal disease issued not more than 3 years and not less than 10 days before arrival in Saudi Arabia. Travelers to Saudi Arabia during pilgrimage months should verify these requirements with a Saudi embassy.

From December through June, vaccination is still recommended for countries in the meningitis belt of Africa.

CDC, Health Information for International Travel, 1996-97.  Atlanta US Department of Health and Human Services, Public Health Service, CDC1997;